Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| First Trust Capital Management L.P. | CDAQF Compass Digital Acquisition Corp. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Rock Springs Capital Management LP | XLO Xilio Therapeutics, Inc. | 13G | 5.23% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | PLRX Pliant Therapeutics, Inc. | 13G | 5.02% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | AKRO Akero Therapeutics, Inc. Common Stock | 13G | 6.4% | Dec 31, 2023 | 2y |
| CAT ROCK CAPITAL MANAGEMENT LP | SEMR SEMrush Holdings, Inc. | 13G | 7.18% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | CLDX Celldex Therapeutics, Inc. | 13G/A | 6.3% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | ATI Ati Inc | 13G/A | 2.5% | Dec 31, 2023 | 2y |
| TENOR CAPITAL MANAGEMENT Co., L.P. | AERT Aeries Technology, Inc. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | GRTS Gritstone bio, Inc. Common Stock | 13G/A | 4.2% | Dec 31, 2023 | 2y |
| ENDEAVOUR CAPITAL ADVISORS INC | CCB Coastal Financial Corp | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | MATX Matson, Inc. | 13G | 5.29% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ANNX Annexon, Inc. | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | VMRK Vivmark Residential | 13G | 5.2% | Dec 31, 2023 | 2y |
| P SCHOENFELD ASSET MANAGEMENT LP | GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares | 13G/A | 1.3% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | NCPL Netcapital Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | WELNF Integrated Wellness Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| REDWOOD CAPITAL MANAGEMENT, LLC | XPOF Xponential Fitness, Inc. | 13G/A | 6.51% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | TARS Tarsus Pharmaceuticals, Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| MOORE CAPITAL MANAGEMENT, LP | FSR Fisker Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Andrew M. Brown | KSCP Knightscope, Inc. | 13G/A | 1.1% | Dec 31, 2023 | 2y |
| Kent Lake Capital LLC | ZIMV ZimVie Inc. Common Stock | 13G/A | 3.8% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | BTLN Brightline Interactive, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MBOT Microbot Medical Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | CRNX Crinetics Pharmaceuticals, Inc. | 13G/A | 2.5% | Dec 31, 2023 | 2y |
| Rock Springs Capital Management LP | INZY Inozyme Pharma, Inc. Common Stock | 13G/A | 5.96% | Dec 31, 2023 | 2y |
| Andrew S. Hedden | SCHL Scholastic Corp | 13G | 7.4% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | RVTY Revvity, Inc. | 13G/A | 12.7% | Dec 31, 2023 | 2y |
| ORION RESOURCE PARTNERS (USA) LP | IAUX i-80 Gold Corp. | 13G/A | 16.6% | Dec 31, 2023 | 2y |
| Advent International, L.P. | OLPX Olaplex Holdings, Inc. | 13G/A | 76.3% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | SRCL Stericycle Inc | 13G/A | 8.6% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | KRYS Krystal Biotech, Inc. | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | MSSAF Metal Sky Star Acquisition Corp | 13G/A | 4.68% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | PTON Peloton Interactive, Inc. | 13G/A | 6% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | AXSM Axsome Therapeutics, Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Madison Avenue Partners, LP | ONL Orion Properties Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | APGE Apogee Therapeutics, Inc. | 13G/A | 6.25% | Dec 31, 2023 | 2y |
| Mountain Crest Global Holdings LLC | MCAG Mountain Crest Acquisition Corp. V | 13G/A | 63.59% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | BHVN Biohaven Ltd. | 13G/A | 3.2% | Dec 31, 2023 | 2y |
| FIDUCIARY MANAGEMENT INC /WI/ | TRS Trimas Corp | 13G | 7.5% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | MTN Vail Resorts Inc | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | FNVT Finnovate Acquisition Corp. Class A Ordinary Shares | 13G | 6.93% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | ERAS Erasca, Inc. | 13G | 5.36% | Dec 31, 2023 | 2y |
| BRUCE A. NORDSTROM | JWN Nordstrom, Inc. | 13G/A | 15.55% | Dec 31, 2023 | 2y |
| SPROTT INC. | SILV SilverCrest Metals Inc. Common Shares | 13G/A | 6% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | VHAQ Viveon Health Acquisition Corp. | 13G/A | 0.64% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | SCAQ Stratim Cloud Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | GLUE Monte Rosa Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BURL Burlington Stores, Inc. | 13G/A | 7.9% | Dec 31, 2023 | 2y |
| 1 Main Capital Management, LLC | ENZ Enzo Biochem, Inc. | 13G/A | 4.95% | Dec 31, 2023 | 2y |